Ipratropium and Moxetumomab Pasudotox-tdfk
Determining the interaction of Ipratropium and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ipratropium
Brand name: Atrovent HFA, Atrovent
Synonyms: Ipratropium inhalation, Ipratropium (Oral Inhalation)
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ipratropium-Moxetumomab pasudotox-tdfk Intravenous
- Ipratropium-Moxifloxacin
- Ipratropium-Moxifloxacin (Systemic)
- Ipratropium-Moxifloxacin Hydrochloride
- Ipratropium-Moxifloxacin Injection
- Ipratropium-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Ipratropium (Oral Inhalation)
- Moxetumomab Pasudotox-tdfk-Ipratropium and Albuterol
- Moxetumomab Pasudotox-tdfk-Ipratropium and Albuterol Inhalation Solution
- Moxetumomab Pasudotox-tdfk-Ipratropium and Albuterol Inhalation Spray
- Moxetumomab Pasudotox-tdfk-Ipratropium and albuterol Inhalation, oral/nebulization
- Moxetumomab Pasudotox-tdfk-Ipratropium Bromide